Armistice Capital »

Citius Oncology shares owned by Armistice Capital

Quarter-by-quarter ownership of Citius Oncology (CTOR) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Citius Oncology

Tip: Access up to 7 years of quarterly data

All positions including Citius Oncology held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Citius Oncology by Armistice Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $16M 7.7M 2.03

More positions owned by Armistice Capital

Iwm Nov5 230.0 P Listed Option Put Option (IWM)
Spy Nov5 634.0 P Listed Option Put Option (SPY)
Ptc Therapeutics Ord Equity (PTCT)
Travere Therapeutics Ord Equity (TVTX)
Supernus Pharmaceuticals Ord Equity (SUPN)
Cytk Jan7 40.0 C Listed Option Call Option (CYTK)
Madrigal Pharmaceuticals Ord Equity (MDGL)
Incyte Ord Equity (INCY)
Neurocrine Biosciences Ord Equity (NBIX)
Immunovant Ord Equity (IMVT)
Dentsply Sirona Ord Equity (XRAY)
Regeneron Pharmaceuticals Ord Equity (REGN)
Freshpet Ord Equity (FRPT)
Amazon Com Ord Equity (AMZN)
Agio Dec5 40.0 C Listed Option Call Option (AGIO)

View all positions for Armistice Capital

Top funds holding Citius Oncology

Armistice Capital
Vanguard Group
Geode Capital Management
XTX Topco
Renaissance Technologies
State Street Corporation
IFP Advisors
Northern Trust
Citadel Advisors
Tower Research Capital
Advisor Group Holdings
Arkadios Wealth Advisors
UBS Group
Farther Finance Advisors

View all funds holding Citius Oncology